Try our Advanced Search for more refined results

Actos Buyers Press 2nd Circ. To Revive Antitrust Claims

By Jeff Zalesin (May 20, 2016, 4:13 PM EDT) -- Buyers of the diabetes drug Actos urged the Second Circuit on Thursday to reinstate their antitrust case accusing Takeda Pharmaceuticals USA Inc. of delaying generic competition for the drug through false patent descriptions, arguing that Takeda has failed to demonstrate that the lower court's dismissal was based on more than premature speculation....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Attached Documents

Related Sections

Law Firms

Companies

Government Agencies

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!